Posted in | News

Cummins to Construct New Emission Solutions Plant and Office Building in Germany

Cummins Inc. today broke ground for a new plant and office building for the Company's Cummins Marktheidenfeld (CMHF) business at a ceremony attended by Cummins Chairman and Chief Executive Officer Tom Linebarger and Marktheidenfeld Mayor Helga Schmidt-Neder.

The new facility will house a state-of-the art plant where Cummins Emission Solutions, a subsidiary of Cummins Inc., will design and manufacture selective catalytic reduction (SCR) dosing systems, a critical part of the emissions controls for diesel engines.

"Our decision to construct this new building here in the heart of Germany will allow us to provide high quality products, service and support to our customers throughout Europe and the world," Linebarger said. "What's more, our work here is a fulfillment of an important part of our mission statement -- that everything we do leads to a cleaner, healthier and safer environment. Not only does our technology reduce emissions, but we are also building this new facility with the kind of green technologies that will reduce our impact on the local environment."

Cummins acquired the SCR dosing business from Hilite International in July 2012, positioning the Company to meet the growing needs of customers as an increasing number of regions adopt tougher emissions standards. The new facility, on land near the current site, will provide room for the business to grow. Construction is expected to begin later this summer with completion in early 2014.

Source: http://cumminsengines.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.